Pfizer swears by its vaccine's efficacy against Delta variant

Pfizer is also looking forward to get authorisation in India once its indemnity request gets approved. Amid this, Pfizer's vaccine's efficacy against Delta variant, which contributed to the second wave of the virus in the country, could help the pharma giant penetrate into the Indian market.

Pfizer swears by its vaccines efficacy against Delta variant
x

New Delhi: American pharmaceutical giant on Thursday said that its vaccine is highly effective against Delta variant of Covid-19. The variant that was first detected in India is now posing as a threat to many countries around the world, including the United States. 


"The data we have today, accumulating from research we are conducting at the lab and including data from those places where the Indian variant, Delta, has replaced the British variant as the common variant, point to our vaccine being very effective, around 90%, in preventing the coronavirus disease, Covid-19," Alon Rappaport, Pfizer's medical director in Israel told local broadcaster Army Radio, Reuters reported.


Pfizer is also looking forward to get authorisation in India once its indemnity request gets approved. Amid this, Pfizer's vaccine's efficacy against Delta variant, which contributed to the second wave of the virus in the country, could help the pharma giant penetrate into the Indian market.


The union health ministry has said that both Covishield and Covaxin, the two vaccines which have been part of India's vaccination drive, are effective against Delta variants. Sputnik V, the Russia-made vaccine available now in India, has also claimed that the vaccine is effective against the Delta variant.


Meanwhile, the Delta Plus variant has posed as  the new challenge in front of India as the country reported first death due to the newest mutation in Bhopal today. 


Next Story